• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌患者细针穿刺抽吸物中雌激素和孕激素受体及Her-2表达与分级的评估

Evaluation of Estrogen and Progesterone Receptors and Her-2 Expression with Grading in the Fine-needle Aspirates of Patients with Breast Carcinoma.

作者信息

Toi Pampa Ch, Neelaiah Siddaraju, Dharanipragada Kadambari, Surendra Kumar

机构信息

Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

出版信息

J Cytol. 2018 Oct-Dec;35(4):223-228. doi: 10.4103/JOC.JOC_127_17.

DOI:10.4103/JOC.JOC_127_17
PMID:30498294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6210817/
Abstract

BACKGROUND

There has been a limited literature with regards to comparison between the pre-operative hormonal/Her-2 neu assessment by immunostaining on fine-needle aspiration (FNA) versus core needle biopsies (CNBs) and their correlation with grading of breast carcinoma.

MATERIALS AND METHODS

Two hundred fifty FNAs and 201 CNBs from 252 patients with breast carcinoma were subjected immunocytochemical/histochemical (ICC/IHC) staining along with the grading by the Robinson cytologic and modified Scarff-Bloom-Richardson scoring systems, respectively. Depending on the material adequacy, IHC was also performed on cell blocks. Sensitivity, specificity, and predictive values of ICC were calculated. The kappa statistics was performed to see the power of the study. Cytologic versus histologic gradings were compared and analysed by percentage analysis.

RESULTS

Sensitivity of ICC on FNAs for ER, PR, and Her-2neu was 49%, 28.8%, and 46%, respectively, while specificity was 84.5%, 90.6%, and 86.6%, respectively, with a fair agreement on kappa statistics. Her-2neu positivity on CNB versus FNA had a moderate agreement. Her-2neu staining of 3+ was seen in most of the Grade-2 tumours on FNA.

CONCLUSIONS

Fairly reliable results on grading and hormonal/Her-2neu status are possible when ICC is performed on qualitatively superior FNA material. This is particularly useful in the management of patients in certain settings like inoperable cases.

摘要

背景

关于通过细针穿刺(FNA)免疫染色与粗针活检(CNB)进行术前激素/Her-2 neu评估及其与乳腺癌分级的相关性的文献有限。

材料与方法

对252例乳腺癌患者的250例FNA和201例CNB进行免疫细胞化学/组织化学(ICC/IHC)染色,并分别采用罗宾逊细胞学评分系统和改良的斯卡夫-布卢姆-理查森评分系统进行分级。根据材料充足性,也对细胞块进行IHC检测。计算ICC的敏感性、特异性和预测值。进行kappa统计以评估研究效能。通过百分比分析比较和分析细胞学分级与组织学分级。

结果

ICC对FNA的雌激素受体(ER)、孕激素受体(PR)和Her-2 neu的敏感性分别为49%、28.8%和46%,而特异性分别为84.5%、90.6%和86.6%,kappa统计显示一致性尚可。CNB与FNA的Her-2 neu阳性具有中等一致性。FNA上大多数2级肿瘤可见3+的Her-2 neu染色。

结论

对质量上乘的FNA材料进行ICC检测时,在分级和激素/Her-2 neu状态方面可获得相当可靠的结果。这在某些情况下,如不可手术的病例中,对患者的管理特别有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ceb/6210817/57db0e0d1fd2/JCytol-35-223-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ceb/6210817/740865b6ff1f/JCytol-35-223-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ceb/6210817/57db0e0d1fd2/JCytol-35-223-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ceb/6210817/740865b6ff1f/JCytol-35-223-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ceb/6210817/57db0e0d1fd2/JCytol-35-223-g005.jpg

相似文献

1
Evaluation of Estrogen and Progesterone Receptors and Her-2 Expression with Grading in the Fine-needle Aspirates of Patients with Breast Carcinoma.乳腺癌患者细针穿刺抽吸物中雌激素和孕激素受体及Her-2表达与分级的评估
J Cytol. 2018 Oct-Dec;35(4):223-228. doi: 10.4103/JOC.JOC_127_17.
2
Cytologic evaluation of prognostic markers in breast carcinoma.乳腺癌预后标志物的细胞学评估
Acta Cytol. 2005 Nov-Dec;49(6):605-10. doi: 10.1159/000326247.
3
Hormone receptor and HER2 assessment in breast carcinoma metastatic to bone: A comparison between FNA cell blocks and decalcified core needle biopsies.激素受体和 HER2 在乳腺癌骨转移中的评估:细针抽吸细胞块与脱钙芯针活检的比较。
Cancer Cytopathol. 2020 Feb;128(2):133-145. doi: 10.1002/cncy.22226. Epub 2019 Dec 28.
4
Evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast.乳腺癌细针穿刺物分级及激素受体免疫染色的评估
J Cytol. 2015 Jan-Mar;32(1):1-5. doi: 10.4103/0970-9371.155222.
5
Fine needle aspirate cell blocks are reliable for detection of hormone receptors and HER-2 by immunohistochemistry in breast carcinoma.细针穿刺抽吸细胞块通过免疫组织化学检测乳腺癌中的激素受体和HER-2是可靠的。
Cytopathology. 2013 Feb;24(1):26-32. doi: 10.1111/j.1365-2303.2011.00934.x. Epub 2012 Jan 3.
6
Immunocytochemical evaluation of HER-2/neu on fine-needle aspirates from primary breast carcinomas.原发性乳腺癌细针穿刺抽吸物中HER-2/neu的免疫细胞化学评估。
Diagn Cytopathol. 2003 Mar;28(3):142-6. doi: 10.1002/dc.10257.
7
Comparative evaluation of the modified Scarff-Bloom-Richardson grading system on breast carcinoma aspirates and histopathology.改良的斯卡夫-布鲁姆-理查森分级系统在乳腺癌穿刺物与组织病理学上的比较评估
Cytojournal. 2012;9:4. doi: 10.4103/1742-6413.92550. Epub 2012 Jan 31.
8
Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients.通过免疫组织化学和免疫细胞化学评估原发性乳腺癌中雌激素和孕激素受体状态的比较:267例连续病例系列
Cytopathology. 2013 Feb;24(1):21-5. doi: 10.1111/j.1365-2303.2012.00997.x. Epub 2012 Jul 12.
9
Hormone receptor expression and Her/2neu amplification in breast carcinoma in a cohort of Sri Lankans.一组斯里兰卡人乳腺癌中的激素受体表达及Her/2neu扩增情况
Ceylon Med J. 2007 Dec;52(4):133-6. doi: 10.4038/cmj.v52i4.916.
10
ER, PR, and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas: a comparison study with formalin-fixed cell blocks and surgical biopsies.原发性和转移性乳腺癌细胞转移细胞学涂片的雌激素受体(ER)、孕激素受体(PR)及人表皮生长因子受体2(Her2)免疫细胞化学:与福尔马林固定细胞块及手术活检的比较研究
Diagn Cytopathol. 2013 Jul;41(7):575-81. doi: 10.1002/dc.22897. Epub 2012 Jul 16.

引用本文的文献

1
Low-Invasive Biomarkers of Canine Mammary Tumours.犬乳腺肿瘤的低侵入性生物标志物
Vet Med Sci. 2025 Mar;11(2):e70280. doi: 10.1002/vms3.70280.
2
Performance of breast fine needle aspiration as an initial diagnostic tool: A large academic hospital experience.乳腺细针抽吸术作为初始诊断工具的性能:一家大型学术医院的经验。
Cytopathology. 2022 Nov;33(6):707-715. doi: 10.1111/cyt.13171. Epub 2022 Sep 9.
3
Rare osteosarcoma cell subpopulation protein array and profiling using imaging mass cytometry and bioinformatics analysis.利用成像质谱细胞术和生物信息学分析对罕见骨肉瘤细胞亚群进行蛋白质芯片分析和分析。

本文引用的文献

1
Comparison of 3-tier cytological grading systems for breast carcinoma.乳腺癌三级细胞学分级系统的比较
ISRN Oncol. 2014 Mar 12;2014:252103. doi: 10.1155/2014/252103. eCollection 2014.
2
Assessment of Her-2/neu status using immunocytochemistry and fluorescence in situ hybridization on fine-needle aspiration cytology smears: experience from a tertiary care centre in India.在细针穿刺细胞学涂片上使用免疫细胞化学和荧光原位杂交技术评估Her-2/neu状态:来自印度一家三级医疗中心的经验。
Diagn Cytopathol. 2014 Aug;42(8):726-31. doi: 10.1002/dc.23088. Epub 2013 Dec 20.
3
Low concordance of biomarkers in histopathological and cytological material from breast cancer.
BMC Cancer. 2020 Jul 31;20(1):715. doi: 10.1186/s12885-020-07203-7.
乳腺癌组织病理学和细胞学材料中生物标志物的一致性较低。
Histopathology. 2014 Jun;64(7):971-80. doi: 10.1111/his.12344. Epub 2014 Feb 5.
4
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.人表皮生长因子受体 2 检测在乳腺癌中的应用:美国临床肿瘤学会/美国病理学家学会临床实践指南更新。
J Clin Oncol. 2013 Nov 1;31(31):3997-4013. doi: 10.1200/JCO.2013.50.9984. Epub 2013 Oct 7.
5
Fine-needle aspiration cytology can play a role in neoadjuvant chemotherapy in operable breast cancer.细针穿刺细胞学检查在可手术乳腺癌的新辅助化疗中可发挥作用。
ISRN Oncol. 2013 Jul 10;2013:935796. doi: 10.1155/2013/935796. Print 2013.
6
ER, PR, and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas: a comparison study with formalin-fixed cell blocks and surgical biopsies.原发性和转移性乳腺癌细胞转移细胞学涂片的雌激素受体(ER)、孕激素受体(PR)及人表皮生长因子受体2(Her2)免疫细胞化学:与福尔马林固定细胞块及手术活检的比较研究
Diagn Cytopathol. 2013 Jul;41(7):575-81. doi: 10.1002/dc.22897. Epub 2012 Jul 16.
7
Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients.通过免疫组织化学和免疫细胞化学评估原发性乳腺癌中雌激素和孕激素受体状态的比较:267例连续病例系列
Cytopathology. 2013 Feb;24(1):21-5. doi: 10.1111/j.1365-2303.2012.00997.x. Epub 2012 Jul 12.
8
Hormone receptor and human epidermal growth factor receptor 2 status evaluation on ThinPrep specimens from breast carcinoma: correlation with histologic sections determination.液基薄层细胞学制片中乳腺癌激素受体和人表皮生长因子受体 2 状态的评估:与组织切片测定的相关性。
Cancer Cytopathol. 2012 Jun 25;120(3):196-205. doi: 10.1002/cncy.20206. Epub 2012 Feb 1.
9
Assessment of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status in the fine needle aspirates of metastatic breast carcinomas.转移性乳腺癌细针穿刺抽吸物中雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER2)状态的评估。
Diagn Cytopathol. 2013 Apr;41(4):308-15. doi: 10.1002/dc.21841. Epub 2011 Nov 1.
10
Robinson's cytological grading on aspirates of breast carcinoma: Correlation with Bloom Richardson's histological grading.罗宾逊对乳腺癌穿刺物的细胞学分级:与布鲁姆·理查森组织学分级的相关性。
J Cytol. 2009 Oct;26(4):140-3. doi: 10.4103/0970-9371.62182.